Lol. "Quick study and should be done shortly". It was also stated in the call that we are already in the process. Probably why it wouldn't be "unreasonable" to think it would be done by the end of the year. Earlier questions produced an answer that said we would get updates as to bioequivalence along the way. That's why I am so sure we'll hear something at any time between now and EOY. If one wants to argue its not a big deal, that's fine. I don't see it that way. Arguing it wasn't said in the call though? OK
News 
Market Data 
Discover 
AI
